ECV outcomes and estimated impact of implementing the Ottawa AF cardioversion protocol
. | Phase I, n (%) . | Phase II, n (%) . | P-value . | Unadjusted RR (95% CI) . | Adjusted RR (95% CI)a . | P-valuea . |
---|---|---|---|---|---|---|
ECV success | 459/500 (91.8) | 386/389 (99.2) | <0.001 | 1.08 (1.05–1.11) | 1.08 (1.05–1.11) | <0.001 |
First shock success | 396/500 (79.2) | 344/389 (88.4) | <0.001 | 1.12 (1.05–1.18) | 1.09 (1.02–1.15) | 0.008 |
Sustained successb | 421/497 (84.7) | 351/383 (91.6) | 0.002 | 1.08 (1.03–1.14) | 1.08 (1.02–1.14) | 0.005 |
. | Phase I, n (%) . | Phase II, n (%) . | P-value . | Unadjusted RR (95% CI) . | Adjusted RR (95% CI)a . | P-valuea . |
---|---|---|---|---|---|---|
ECV success | 459/500 (91.8) | 386/389 (99.2) | <0.001 | 1.08 (1.05–1.11) | 1.08 (1.05–1.11) | <0.001 |
First shock success | 396/500 (79.2) | 344/389 (88.4) | <0.001 | 1.12 (1.05–1.18) | 1.09 (1.02–1.15) | 0.008 |
Sustained successb | 421/497 (84.7) | 351/383 (91.6) | 0.002 | 1.08 (1.03–1.14) | 1.08 (1.02–1.14) | 0.005 |
ECV outcomes and estimated impact of implementing the Ottawa AF cardioversion protocol
. | Phase I, n (%) . | Phase II, n (%) . | P-value . | Unadjusted RR (95% CI) . | Adjusted RR (95% CI)a . | P-valuea . |
---|---|---|---|---|---|---|
ECV success | 459/500 (91.8) | 386/389 (99.2) | <0.001 | 1.08 (1.05–1.11) | 1.08 (1.05–1.11) | <0.001 |
First shock success | 396/500 (79.2) | 344/389 (88.4) | <0.001 | 1.12 (1.05–1.18) | 1.09 (1.02–1.15) | 0.008 |
Sustained successb | 421/497 (84.7) | 351/383 (91.6) | 0.002 | 1.08 (1.03–1.14) | 1.08 (1.02–1.14) | 0.005 |
. | Phase I, n (%) . | Phase II, n (%) . | P-value . | Unadjusted RR (95% CI) . | Adjusted RR (95% CI)a . | P-valuea . |
---|---|---|---|---|---|---|
ECV success | 459/500 (91.8) | 386/389 (99.2) | <0.001 | 1.08 (1.05–1.11) | 1.08 (1.05–1.11) | <0.001 |
First shock success | 396/500 (79.2) | 344/389 (88.4) | <0.001 | 1.12 (1.05–1.18) | 1.09 (1.02–1.15) | 0.008 |
Sustained successb | 421/497 (84.7) | 351/383 (91.6) | 0.002 | 1.08 (1.03–1.14) | 1.08 (1.02–1.14) | 0.005 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.